A genotype-directed phase I-IV dose-finding study of irinotecan in combination with fluorouracil/leucovorin as first-line treatment in advanced colorectal cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/21654688

Br. J. Cancer 2011 Jun 28 105 1 53-7

Download in:

View as

Triples

General Info

PMID
21654688